Influenzavirus B Infection Drug Market Report

Europe Influenzavirus B Infection Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 21, 2020
  • PAGES：147
  • REPORT CODE：GMM444079
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Influenzavirus B Infection Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Influenzavirus B Infection Drug Market Segmentations:

    By Player:

    • ContraFect Corp

    • BioCryst Pharmaceuticals Inc

    • Amarillo Biosciences Inc

    • Cadila Healthcare Ltd

    • Mucosis BV

    • Green Cross Corp

    • Romark Laboratories LC

    • Kineta Inc

    • Medicago Inc

    • Novavax Inc

    • AbbVie Inc

    • Fujifilm Holdings Corporation

    • GlaxoSmithKline Plc

    • Park Active Molecules

    • Inovio Pharmaceuticals Inc

    • Aphios Corp

    • Daiichi Sankyo Company Ltd

    • MedImmune LLC

    • Adimmune Corp

    • Altravax Inc

    By Type:

    • APP-309

    • CF-403

    • GC-3106A

    • KIN-1400

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenzavirus B Infection Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of APP-309 from 2014 to 2026

    • 1.3.2 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of CF-403 from 2014 to 2026

    • 1.3.3 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of GC-3106A from 2014 to 2026

    • 1.3.4 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of KIN-1400 from 2014 to 2026

    • 1.3.5 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.2 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Influenzavirus B Infection Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Influenzavirus B Infection Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of APP-309

      • 3.4.2 Market Size and Growth Rate of CF-403

      • 3.4.3 Market Size and Growth Rate of GC-3106A

      • 3.4.4 Market Size and Growth Rate of KIN-1400

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Influenzavirus B Infection Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Influenzavirus B Infection Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Influenzavirus B Infection Drug for Clinic

      • 4.4.2 Market Size and Growth Rate of Influenzavirus B Infection Drug for Hospital

      • 4.4.3 Market Size and Growth Rate of Influenzavirus B Infection Drug for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Influenzavirus B Infection Drug Production Analysis by Top Regions

    • 5.2 Europe Influenzavirus B Infection Drug Consumption Analysis by Top Regions

    • 5.3 Europe Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Influenzavirus B Infection Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Influenzavirus B Infection Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Influenzavirus B Infection Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Influenzavirus B Infection Drug Landscape Analysis

    • 7.1 Germany Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 7.2 Germany Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    8. UK Influenzavirus B Infection Drug Landscape Analysis

    • 8.1 UK Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 8.2 UK Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    9. France Influenzavirus B Infection Drug Landscape Analysis

    • 9.1 France Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 9.2 France Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    10. Italy Influenzavirus B Infection Drug Landscape Analysis

    • 10.1 Italy Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 10.2 Italy Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    11. Spain Influenzavirus B Infection Drug Landscape Analysis

    • 11.1 Spain Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 11.2 Spain Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    12. Poland Influenzavirus B Infection Drug Landscape Analysis

    • 12.1 Poland Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 12.2 Poland Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    13. Russia Influenzavirus B Infection Drug Landscape Analysis

    • 13.1 Russia Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 13.2 Russia Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    14. Switzerland Influenzavirus B Infection Drug Landscape Analysis

    • 14.1 Switzerland Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    15. Turkey Influenzavirus B Infection Drug Landscape Analysis

    • 15.1 Turkey Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 15.2 Turkey Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 16.3.2 Finland Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 16.3.3 Norway Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Influenzavirus B Infection Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Influenzavirus B Infection Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Influenzavirus B Infection Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Influenzavirus B Infection Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 ContraFect Corp

      • 19.1.1 ContraFect Corp Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 BioCryst Pharmaceuticals Inc

      • 19.2.1 BioCryst Pharmaceuticals Inc Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Amarillo Biosciences Inc

      • 19.3.1 Amarillo Biosciences Inc Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Cadila Healthcare Ltd

      • 19.4.1 Cadila Healthcare Ltd Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Mucosis BV

      • 19.5.1 Mucosis BV Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Green Cross Corp

      • 19.6.1 Green Cross Corp Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Romark Laboratories LC

      • 19.7.1 Romark Laboratories LC Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Kineta Inc

      • 19.8.1 Kineta Inc Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Medicago Inc

      • 19.9.1 Medicago Inc Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Novavax Inc

      • 19.10.1 Novavax Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 AbbVie Inc

      • 19.11.1 AbbVie Inc Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Fujifilm Holdings Corporation

      • 19.12.1 Fujifilm Holdings Corporation Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 GlaxoSmithKline Plc

      • 19.13.1 GlaxoSmithKline Plc Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Park Active Molecules

      • 19.14.1 Park Active Molecules Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Inovio Pharmaceuticals Inc

      • 19.15.1 Inovio Pharmaceuticals Inc Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Aphios Corp

      • 19.16.1 Aphios Corp Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Daiichi Sankyo Company Ltd

      • 19.17.1 Daiichi Sankyo Company Ltd Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 MedImmune LLC

      • 19.18.1 MedImmune LLC Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Adimmune Corp

      • 19.19.1 Adimmune Corp Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Altravax Inc

      • 19.20.1 Altravax Inc Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 84 Figures and 157 Tables)

    • Figure Product Picture

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of APP-309 from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of CF-403 from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of GC-3106A from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of KIN-1400 from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Influenzavirus B Infection Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Influenzavirus B Infection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Influenzavirus B Infection Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Influenzavirus B Infection Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Influenzavirus B Infection Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Influenzavirus B Infection Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of APP-309

    • Figure Market Size and Growth Rate of CF-403

    • Figure Market Size and Growth Rate of GC-3106A

    • Figure Market Size and Growth Rate of KIN-1400

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Influenzavirus B Infection Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Influenzavirus B Infection Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Others

    • Table Europe Influenzavirus B Infection Drug Production by Major Regions

    • Table Europe Influenzavirus B Infection Drug Production Share by Major Regions

    • Figure Europe Influenzavirus B Infection Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Influenzavirus B Infection Drug Consumption by Major Regions

    • Table Europe Influenzavirus B Infection Drug Consumption Share by Major Regions

    • Table Germany Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table UK Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table France Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Italy Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Spain Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Poland Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Russia Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Influenzavirus B Infection Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Germany Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table UK Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table UK Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table UK Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table France Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table France Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table France Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Italy Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Spain Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Poland Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Russia Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Turkey Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenzavirus B Infection Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenzavirus B Infection Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenzavirus B Infection Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Influenzavirus B Infection Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of ContraFect Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ContraFect Corp

    • Figure Sales and Growth Rate Analysis of ContraFect Corp

    • Figure Revenue and Market Share Analysis of ContraFect Corp

    • Table Product and Service Introduction of ContraFect Corp

    • Table Company Profile and Development Status of BioCryst Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals Inc

    • Table Product and Service Introduction of BioCryst Pharmaceuticals Inc

    • Table Company Profile and Development Status of Amarillo Biosciences Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amarillo Biosciences Inc

    • Figure Sales and Growth Rate Analysis of Amarillo Biosciences Inc

    • Figure Revenue and Market Share Analysis of Amarillo Biosciences Inc

    • Table Product and Service Introduction of Amarillo Biosciences Inc

    • Table Company Profile and Development Status of Cadila Healthcare Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cadila Healthcare Ltd

    • Figure Sales and Growth Rate Analysis of Cadila Healthcare Ltd

    • Figure Revenue and Market Share Analysis of Cadila Healthcare Ltd

    • Table Product and Service Introduction of Cadila Healthcare Ltd

    • Table Company Profile and Development Status of Mucosis BV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mucosis BV

    • Figure Sales and Growth Rate Analysis of Mucosis BV

    • Figure Revenue and Market Share Analysis of Mucosis BV

    • Table Product and Service Introduction of Mucosis BV

    • Table Company Profile and Development Status of Green Cross Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross Corp

    • Figure Sales and Growth Rate Analysis of Green Cross Corp

    • Figure Revenue and Market Share Analysis of Green Cross Corp

    • Table Product and Service Introduction of Green Cross Corp

    • Table Company Profile and Development Status of Romark Laboratories LC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Romark Laboratories LC

    • Figure Sales and Growth Rate Analysis of Romark Laboratories LC

    • Figure Revenue and Market Share Analysis of Romark Laboratories LC

    • Table Product and Service Introduction of Romark Laboratories LC

    • Table Company Profile and Development Status of Kineta Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kineta Inc

    • Figure Sales and Growth Rate Analysis of Kineta Inc

    • Figure Revenue and Market Share Analysis of Kineta Inc

    • Table Product and Service Introduction of Kineta Inc

    • Table Company Profile and Development Status of Medicago Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicago Inc

    • Figure Sales and Growth Rate Analysis of Medicago Inc

    • Figure Revenue and Market Share Analysis of Medicago Inc

    • Table Product and Service Introduction of Medicago Inc

    • Table Company Profile and Development Status of Novavax Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax Inc

    • Figure Sales and Growth Rate Analysis of Novavax Inc

    • Figure Revenue and Market Share Analysis of Novavax Inc

    • Table Product and Service Introduction of Novavax Inc

    • Table Company Profile and Development Status of AbbVie Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc

    • Figure Sales and Growth Rate Analysis of AbbVie Inc

    • Figure Revenue and Market Share Analysis of AbbVie Inc

    • Table Product and Service Introduction of AbbVie Inc

    • Table Company Profile and Development Status of Fujifilm Holdings Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Holdings Corporation

    • Figure Sales and Growth Rate Analysis of Fujifilm Holdings Corporation

    • Figure Revenue and Market Share Analysis of Fujifilm Holdings Corporation

    • Table Product and Service Introduction of Fujifilm Holdings Corporation

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Park Active Molecules

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Park Active Molecules

    • Figure Sales and Growth Rate Analysis of Park Active Molecules

    • Figure Revenue and Market Share Analysis of Park Active Molecules

    • Table Product and Service Introduction of Park Active Molecules

    • Table Company Profile and Development Status of Inovio Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inovio Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Inovio Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Inovio Pharmaceuticals Inc

    • Table Product and Service Introduction of Inovio Pharmaceuticals Inc

    • Table Company Profile and Development Status of Aphios Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aphios Corp

    • Figure Sales and Growth Rate Analysis of Aphios Corp

    • Figure Revenue and Market Share Analysis of Aphios Corp

    • Table Product and Service Introduction of Aphios Corp

    • Table Company Profile and Development Status of Daiichi Sankyo Company Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Company Ltd

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Company Ltd

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Company Ltd

    • Table Product and Service Introduction of Daiichi Sankyo Company Ltd

    • Table Company Profile and Development Status of MedImmune LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune LLC

    • Figure Sales and Growth Rate Analysis of MedImmune LLC

    • Figure Revenue and Market Share Analysis of MedImmune LLC

    • Table Product and Service Introduction of MedImmune LLC

    • Table Company Profile and Development Status of Adimmune Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adimmune Corp

    • Figure Sales and Growth Rate Analysis of Adimmune Corp

    • Figure Revenue and Market Share Analysis of Adimmune Corp

    • Table Product and Service Introduction of Adimmune Corp

    • Table Company Profile and Development Status of Altravax Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altravax Inc

    • Figure Sales and Growth Rate Analysis of Altravax Inc

    • Figure Revenue and Market Share Analysis of Altravax Inc

    • Table Product and Service Introduction of Altravax Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US